ABSTRACT Background: Although a high intake of some flavonoid subclasses may reduce cardiovascular disease mortality, data regarding the in vivo mechanisms of action are limited. Objective: We examined associations between habitual flavonoid intakes and direct measures of arterial stiffness, central blood pressure, and atherosclerosis. Design: In a cross-sectional study of 1898 women aged 18-75 y from the TwinsUK registry, intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, polymers, flavonols, and flavones) were calculated from validated food-frequency questionnaires by using an updated and extended USDA database. Direct measures of arterial stiffness and atherosclerosis included central systolic blood pressure (cSBP), central diastolic blood pressure, mean arterial pressure (MAP), augmentation index, pulse wave velocity (PWV), and intima-media thickness. Results: In multivariate analyses, a higher anthocyanin intake was associated with significantly lower cSBP (mean 6 SE: 23.0 6 1.4 mm Hg for quintile 5 compared with quintile 1; P-trend = 0.02), MAP (22.3 6 1.2 mm Hg for quintile 5 compared with quintile 1; P-trend = 0.04), and PWV (20.4 6 0.2 m/s for quintile 5 compared with quintile 1; P-trend = 0.04), whereas a higher flavone intake was associated with a lower PWV (20.4 6 0.2 m/s for quintile 5 compared with quintile 1; P-trend = 0.04). Although a higher wine and berry intake was associated with a lower PWV, no associations were observed for total and other flavonoid subclasses. Conclusions: These data, which include direct measures of arterial stiffness and thickness, suggest that higher intake of anthocyanins and flavones are inversely associated with lower arterial stiffness. The intakes of anthocyanins associated with these findings could be incorporated into the diet by the consumption of 1-2 portions of berries daily and are, therefore, relevant for public health strategies to reduce cardiovascular disease risk.
INTRODUCTION
Dietary flavonoids are a diverse range of bioactive compounds that are present in many commonly consumed fruit, vegetables, grains, herbs, and drinks (including tea, wine, and fruit juices) (1) . In population-based studies, some flavonoid subclasses, including anthocyanins, flavanones, and flavonols, have been associated with a reduction in risk of hypertension, stroke, and cardiovascular disease (CVD) 4 (2) (3) (4) (5) . Complementary in vitro mechanistic data suggested that such flavonoid subclasses can improve vascular function by increasing the bioavailability of nitric oxide, which is a potent endothelial-derived vasodilator, through a variety of molecular mechanisms (6) (7) (8) .
Although dietary flavonoids share a common basic chemical backbone structure, they are divided into 6 subclasses [flavonols, flavones, flavanones, flavan-3-ols, isoflavones, and anthocyanins and their oligomeric and polymeric forms (ie, procyanidins and other polymers)] on the basis of the linkage of the aromatic ring to the heterocyclic ring, oxidation state, and functional groups attached to the heterocyclic ring. These subtle differences in chemical structure can alter absorption, distribution, metabolism, and elimination and bioactivity, which highlight the importance of investigating intake-phenotype associations with subclasses in addition to flavonoid intake as a whole (9, 10) .
Arterial stiffness provides assessment of both the structure and function of the artery (11) , and pulse wave velocity (PWV) is considered the gold standard tool and most consistently predictive of CVD risk (12) . The measurement of central blood pressure, as measured by using the augmentation index (AI), is considered a strong predictor of atherosclerosis (11, 13) , and intima-media thickness (IMT) correlates with CVD incidence (14) .
A number of randomized controlled trials have examined the impact of flavonoid-rich foods such as berries and chocolate on markers of vascular health (15, 16) . Most evidence relates to cocoa interventions, rich in flavan-3-ols, with data that suggested beneficial effects on mean arterial pressure (MAP) (21.64 mm Hg), diastolic blood pressure (DBP) (21.60 mm Hg), and flowmediated dilation (FMD) (1.34%) (17) . Few data are available for anthocyanin-rich food, although a 4-wk cranberry juice intervention (94 mg anthocyanins/d) resulted in a significant decrease in PWV (0.5 m/s; 6%), and blueberry supplementation for 8 wk (742 mg anthocyanins/d) decreased both systolic blood pressure (SBP) and DBP by 6% and 4%, respectively (18, 19) .
To our knowledge, no previous cross-sectional studies have examined associations between flavonoid subclass intakes, which are measured by using the most comprehensive and up-to-date food-composition databases, and in vivo measures of arterial stiffness, central blood pressure, and atherosclerosis, including PWV, AI, and IMT. Therefore, we examined cross-sectional associations between flavonoid subclasses and these endpoints in a cohort of healthy women aged 18-75 y. PWV and IMT were measured in a subset of participants who were part of a planned longitudinal study on the heritability of arterial stiffness. On the basis of previous research, it was hypothesized that participants with higher intakes of anthocyanins and flavan-3-ols would have lower measures of arterial stiffness and central blood pressure.
SUBJECTS AND METHODS

Study population
The current study used data collected from study participants in the TwinsUK registry, which is a nationwide registry that consists of adult twin volunteers recruited from the general population through national media campaigns in the United Kingdom (20) . All participants were unaware of the specific hypotheses being tested and were not selected on the basis of the variables being studied. Zygosity was derived by using a questionnaire and confirmed with multiplex DNA fingerprinting (PE Applied Biosystems). Informed consent was obtained from all participants, and ethical approval for the study was gained from St Thomas' Hospital Research Ethics Committee. Participants included in this analysis were women aged 18-75 y who were a sample of the total population group that had both completed food-frequency questionnaires (FFQs) and attended for clinical assessment of arterial stiffness and atherosclerosis progression between 1996 and 2007. The population has previously been shown to be representative of the general population in terms of blood pressure and dietary intake (20, 21) .
Assessment of arterial stiffness, central blood pressure, and IMT Measurements were performed during a single visit to a quiet, temperature-controlled clinical laboratory (22 8 C to 24 8 C). Peripheral SBP and peripheral DBP (average of 2 readings) were measured with an automated cuff sphygmomanometer (OMRON HEM713C). Measures of central blood pressure and AI were obtained with the subject in a supine position by using the SphygmoCor system (Atcor Medical), as described previously for this cohort (22) . Applanation tonometry of the radial artery with a high-fidelity transducer (Millar Instruments) was used to obtain an averaged radial pulse. The radial artery pressure waveform was calibrated to the supine brachial blood pressure. The inbuilt transfer function in the SphygmoCor system provided a corresponding aortic pulse waveform from which central SBP (cSBP), central DBP, central pulse pressure, MAP, and AI were identified. Intraoperator and interoperator reproducibility, which were expressed as intraclass correlations, were 0.82 and 0.84, respectively (23) .
In a subset of the population (n = 728) who were part of a planned longitudinal study on the heritability of arterial stiffness, PWV was calculated from sequential recordings of electrocardiogram-referenced carotid and femoral pressure waveforms obtained by using tonometry with the same device and transducer. The path distance between carotid and femoral sites was estimated from the distance between each artery location and the sternal notch (24) . Carotid IMT was measured in the same population subset in which PWV was measured on the near and far wall of the left and right common carotid arteries by ultrasound (Siemens CV70). For each segment, multiple measurements were made with automated edge-detective software (Medical Imaging Applications). The image with maximum thickness was selected, and average values of the IMT of each of the 4 segments were used in subsequent analyses (24) .
Assessment of flavonoid intakes
Participants completed a 131-item validated FFQ (25, 26) . Flavonoid intakes were calculated by using the updated USDA databases for the flavonoid and proanthocyanin contents of food as primary data sources (27, 28) . For foods in the FFQ for which there were no values available in the USDA database, we searched phenol explorer (www.phenol-explorer.eu) to ensure that all available high-quality data on flavonoid values were included in the database. Values for individual flavonoid compounds were assigned to each of the foods listed in the FFQ, and recipe values for each ingredient in the dishes were assigned by using the previously described data sources.
Intakes of individual flavonoids were calculated as the frequency of each food multiplied by the flavonoid content of the food for the appropriate portion size (29) . Intakes were derived for the following 6 main subclasses habitually consumed: flavanones (eriodictyol, hesperetin, and naringenin), anthocyanins (cyanidin, delphinidin, malvidin, pelargonidin, petunidin, and peonidin), flavan-3-ols (catechins and epicatechins), flavonols (quercetin, kaempferol, myricetin, and isohamnetin), flavones (luteolin and apigenin), and polymers (including proanthocyanidins, theaflavins, and thearubigins). Total flavonoid intakes were derived by the addition of the 6 component subclasses. Flavonoid intakes were energy adjusted by using the residual method, and the main food sources of the various subclasses were calculated at the population level (ie, the flavonoid intake from a specific food for all participants divided by flavonoid intake from all foods for all participants). Dietary data were excluded if answers for .10 food items were left blank or the ratio of the FFQ-derived estimate of the total energy intake to the estimated basal metabolic rate of subjects fell 2 SDs outside the mean ratio (,0.52 or .2.58) (21) .
Assessment of covariates
Intakes of energy and nutrients associated with arterial stiffness were determined from the FFQ previously described. Height was measured to the nearest 0.5 cm by using a wall-mounted stadiometer, weight (light clothing only) was measured to the nearest 0.1 kg by using digital scales, and BMI (in kg/m 2 ) was calculated. Information on family medical history, medication use, lifestyle, and demographic variables were obtained by using a standardized nurse-administered questionnaire. Physical activity was classified as inactive, moderate, or active during work, home, and leisure time by using a questionnaire that was strongly correlated with more in-depth assessment of time spent in physical activity in this cohort (30) .
Statistical analysis
Statistical analyses were performed with Stata statistical software (version 11.0; Stata Corp). The analysis focused on associations in twins as individuals, with SEs adjusted through robust regression by using the cluster option in Stata to take into account the dependency within twin pairs. Quintiles of different subclasses of flavonoid intake were calculated, and ANCOVA was used to calculate adjusted means and to evaluate statistical differences in cardiovascular outcomes in these groups. Effect sizes are presented as the difference in outcome measures between extreme quintiles. The main dietary sources of subclasses were calculated only for those that showed significant associations with the outcome measures in the primary analysis, and only total fruit and vegetables and foods that contributed to .10% of intake were included. Tertiles rather than quintiles of food intake were used to ensure equal numbers of participants in each of the categories because of the limited variability in the set frequencies from the FFQ. All models were adjusted for age (y), current smoking (yes or no), physical activity (inactive, moderately active, or active), BMI, use of hormone replacement therapy (yes or no), use of blood pressure or statin medication (yes or no), use of vitamin supplements (yes or no), use of oral contraceptives (yes or no), menopausal status (premenopausal or postmenopausal), family history of heart disease or hypertension (yes or no), and the intake of nutrients associated with cardiovascular function [energy (kcal); alcohol (g); SFAs, MUFAs, and PUFAs (percentage of energy); dietary fiber (g); and sodium (mg)].
RESULTS
Baseline characteristics of the participant population of 1898 women are presented in Table 1 ; 71% of the study population were dizygotic, and 29% of the study population were monozygotic twin pairs. The mean (6SD) age of participants was 46 6 12.4 y, and the mean (6SD) BMI was 25.3 6 4.47. Nineteen percent of participants were current smokers, and in relation to physical activity, 23% of participants were active, 54% of participants were moderately active, and 23% of participants were inactive. More than one-half of participants took vitamin supplements (55%), and few participants were taking blood pressure or statin medication (11%).
The mean total flavonoid intake was 1.15 g/d (IQR: 0.56-1.69 g/d), and polymers (including proanthocyanidins, theaflavins, and thearubigins) made the greatest contribution to the total intake (72%). Overall, tea was the main source of total flavonoid (80%), flavan-3-ol (91%), flavonol (63%), and polymer (83%) intake ( Figure 1) . Four foods contributed .10% of anthocyanin intake as follows: grapes (20%), pears (23%), wine (22%), and berries (strawberries and raspberries) (13%).
Total flavonoid intake was not associated with any measures of arterial stiffness, central blood pressure, or atherosclerosis. In multivariate analyses, which were adjusted for a number of dietary and lifestyle factors, a higher anthocyanin intake was associated with significantly lower peripheral SBP (P-trend = 0.01), cSBP (P-trend = 0.02), and MAP (P-trend = 0.04) ( Table  2) . When extreme quintiles of anthocyanin intake were compared, mean (6SE) cSBP and MAP were significantly lower after higher intakes by 3.04 6 1.41 and 2.31 6 1.16 mm Hg, respectively (Table 2) . Anthocyanin intakes were also marginally associated with lower central DBP (1.86 6 1.01 mm Hg for quintile 5 compared with quintile 1; P-trend = 0.05) and peripheral DBP (1.85 6 0.99 mm Hg for quintile 5 compared with quintile 1; P-trend = 0.06) (data not shown).
Participants with the highest intakes of anthocyanins and flavones had lower PWV (n = 728) (P-trend = 0.04 for both subclasses; Table 2 ). The mean (6SE) difference in PWV between extreme quintiles of intake was 0. 4 (Table 3) . No associations were observed for total flavonoid intake, other flavonoid subclasses (ie, flavanones, flavan-3-ols, flavonols, and polymers), pulse pressure, AI, or IMT.
DISCUSSION
To our knowledge, this is the first cross-sectional study to examine associations between flavonoid subclasses and a range of in vivo measures of arterial stiffness and central blood pressure associated with cardiovascular risk. The analysis used recently updated and more comprehensive flavonoid-composition databases that more accurately captured the wide range of flavonoids present in the habitual diet than in many previous studies.
We showed that a higher intake of anthocyanins was associated with significantly lower cSBP and MAP. In subgroup analyses (n = 728), we also observed a significantly lower PWV with an increased intake of anthocyanins. Furthermore, food-based analyses suggested that wine and berries, which contributed 22% and 13% of the total anthocyanin intake, respectively, were associated with lower PWV. The difference between extreme quintiles of intake was 0.3 m/s. The magnitude of associations observed between anthocyanin intake and SBP (3-4 mm Hg) was similar to that previously reported for smoking (31) and 2-fold higher than that reported for an increase in fruit and vegetable intake of 1.4 portions/ d (32) . For PWV (0.4 m/s), our findings are comparable to those reported for dietary intakes of isoflavones and lignans (33) and equivalent to the effects of 10-y aging in women ,50 y (34). Our findings are also of a similar magnitude, although in the opposing direction from the effects reported for a dietary pattern defined by high meat and alcohol consumption and low micronutrient intake (35) . The magnitude of our findings is also comparable to that reported in randomized controlled trials with a 4-wk intervention with cranberry juice that contained 94 mg anthocyanins, which reduced PWV by 0.5 m/s (18) . In the current analysis, a difference in PWV of 0.4 m/s shown between extreme quintiles of anthocyanin intake equated to a 44-mg mean difference in intake. These findings highlight the importance of incorporating more fruit, particularly berries, into our diets because 44 mg anthocyanins are provided by w1-2 portions of either strawberries, raspberries, or blueberries (27, 29) .
The ability of aortic stiffness, as assessed by PWV, and subclinical atherosclerosis as assessed by IMT, to predict future cardiovascular events is now relatively well established (36) . The publication of reference values for PWV (37) and the inclusion of PWV and IMT as adjuncts to traditional CVD risk biomarkers in the 2007 European Society of Hypertension and Cardiology guidelines for hypertension management (38) are testaments to the recognition of their prognostic ability. Accordingly, these markers of vascular health represent important targets for the development of pharmacologic and lifestyle approaches aimed at the reduction of CVD risk.
Our results provide a potential explanation to support the risk reduction in hypertension and CVD mortality observed with higher anthocyanin intakes in recent large prospective studies (2, 5) and are consistent with blueberry and other berry intervention studies that reported decreases in SBP (19, 39) . Our findings are also in agreement with limited data from dietary intervention trials that have shown that cranberry juice high in anthocyanins reduces PWV over 4 wk (18) . These observed effects of a higher anthocyanin intake on SBP and PWV are supported by several in vitro mechanistic study findings, in which anthocyanins have been shown to affect signaling pathways involved in inflammation (40, 41) and exert antiangiogenic effects including the inhibition of platelet-derived growth-factor signaling (42) . In addition, in animal studies that involved apolipoprotein E-deficient mice, anthocyanin ingestion directly inhibited atherosclerosis development (43) and suppressed the development of atherosclerotic lesions (44) .
In relation to the flavone subclass, although the mean (6SD) intake of this subclass was low (2.0 6 1.46 mg/d), we observed that higher intakes were associated with lower PWV. The flavone luteolin has previously been associated with reduced risk of myocardial infarction in a longitudinal study (45) , whereas in an animal model, apigenin markedly increased nitric oxide concentrations and evoked endothelium-dependent vasorelaxation (46) , which is known to improve PWV independent of blood pressure (47) . Dietary potassium has also been shown to be associated with blood pressure and PWV (48) , although the addition of potassium to our models did not attenuate the relation between arterial stiffness, central blood pressure, and flavones or anthocyanins (data not shown). It was surprising that we did not observe associations for other subclasses previously reported to be associated with arterial stiffness and blood pressure, including flavan-3-ols. Randomized controlled trials have consistently shown beneficial effects for foods rich in flavan-3-ols on blood pressure and endothelial function assessed by FMD. A previous meta-analysis showed that chocolate can increase FMD after acute (3.19%) and chronic (1.34%) intake and reduce MAP (-1.64 mm Hg) and DBP (-1.60 mm Hg) (17) . It is possible that the lack of association in the current study was the result of the low mean intake of flavan-3-ols. A meta-analysis of the effects of flavan-3-ols on cardiovascular health reported the greatest effects for SBP and DBP when epicatechin intake was .50 mg/d, whereas in the current study, the mean intake of epicatechin was only 24 mg/d (IQR: 14.7-33.6 mg/d) (17) .
Strengths of the current study include the large sample size and use of in vivo measures of arterial stiffness and central blood pressure. The method used to collect the dietary data had been previously validated and was shown to be suitable for ranking subjects according to their usual intake of flavonoid-rich foods, including fruit and vegetables (49) . An additional strength was the range of flavonoid subclasses investigated and the accurate assessment of a range of cardiovascular measures, including PWV, which is a biomarker of cardiovascular risk (12) . It was notable that the associations observed in the current analysis were shown in a population with a high proportion of normotensive individuals because it is plausible that any associations would be more pronounced in a hypertensive group. These participants have been previously shown to be representative of the general population in terms of blood pressure and diet (20, 21) , and these data have been used in previous studies of dietary exposure (50) .
Limitations of the current study include the cross-sectional design that meant we were unable to infer causality because of many potential confounders. High flavonoid intakes may be representative of a healthy lifestyle in general, and even though we adjusted for a range of dietary and lifestyle confounder variables (including age, smoking, physical activity, BMI, medication use, and intakes of other nutrients associated with vascular health), residual confounding could not be ruled out because of the observational nature of the study. The USDA foodcomposition databases used in the current analysis allowed us to quantify a broad range of flavonoid subclass intakes more robustly than in most previous analyses. However, flavonoid composition is an emerging area, and there is wide variability in the flavonoid content of foods depending on geographical origin, growing season, different cultivars, agricultural methods and processing, and a lack of biomarkers to integrate intake with the extensive metabolism these compounds undergo in vivo, which suggested that existing measurement error cannot be ruled out (2) .
In conclusion, our data suggest a protective role for anthocyanins and flavones on arterial stiffness and central blood pressure, with significant improvements in PWV and cSBP similar to previously reported lifestyle factors such as age, not smoking, or having a healthy diet (31) (32) (33) (34) (35) . These results are of public health importance because intakes of flavonoids associated with these findings are easily achievable in the habitual diet and make a significant contribution to the knowledge base needed to refine the current, rather general, fruit and vegetable dietary recommendations. The findings highlight the need for more intervention trials on anthocyanins and anthocyanin-rich foods for the prevention and management of 
